UnitedHealth Group (NYSE:UNH) updated its FY22 earnings guidance on Monday. The company provided EPS guidance of $21.10-21.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $21.63. The company issued revenue guidance of $317-320 billion, compared to the consensus revenue estimate of $310.64 billion.UnitedHealth Group also updated its FY 2021 guidance to $18.750-$18.900 EPS.
Several equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $421.00 to $477.00 and gave the company a buy rating in a research report on Tuesday, November 16th. Royal Bank of Canada upped their price objective on UnitedHealth Group from $473.00 to $476.00 and gave the company an outperform rating in a research report on Friday, October 15th. SVB Leerink assumed coverage on UnitedHealth Group in a report on Monday, September 27th. They set an outperform rating and a $480.00 price target on the stock. Morgan Stanley increased their price target on UnitedHealth Group from $488.00 to $499.00 and gave the company an overweight rating in a report on Friday, October 15th. Finally, Mizuho raised their target price on UnitedHealth Group from $455.00 to $500.00 and gave the stock a buy rating in a report on Wednesday, November 10th. One analyst has rated the stock with a hold rating, twenty-one have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group presently has an average rating of Buy and a consensus price target of $477.35.
Shares of UnitedHealth Group stock traded up $12.09 during trading on Monday, reaching $452.00. 4,078,497 shares of the stock traded hands, compared to its average volume of 2,943,138. The company has a market capitalization of $425.72 billion, a price-to-earnings ratio of 28.04, a P/E/G ratio of 1.75 and a beta of 0.85. The business has a fifty day simple moving average of $432.32 and a two-hundred day simple moving average of $418.81. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group has a 52-week low of $320.35 and a 52-week high of $466.00.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.41 by $0.11. The firm had revenue of $72.34 billion during the quarter, compared to analyst estimates of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter last year, the business posted $3.51 earnings per share. On average, research analysts predict that UnitedHealth Group will post 18.84 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 14th. Investors of record on Monday, December 6th will be given a $1.45 dividend. The ex-dividend date is Friday, December 3rd. This represents a $5.80 annualized dividend and a yield of 1.28%. UnitedHealth Group’s dividend payout ratio is currently 35.98%.
In related news, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction dated Tuesday, November 23rd. The stock was sold at an average price of $444.70, for a total value of $1,111,750.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Stephen J. Hemsley sold 75,000 shares of the firm’s stock in a transaction dated Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 82,500 shares of company stock valued at $36,855,125. 0.55% of the stock is currently owned by company insiders.
Institutional investors have recently bought and sold shares of the company. OLD Mission Capital LLC bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $439,000. Camden National Bank raised its stake in shares of UnitedHealth Group by 5.5% during the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock valued at $667,000 after acquiring an additional 100 shares in the last quarter. Finally, Morgan Stanley raised its stake in shares of UnitedHealth Group by 9.7% during the second quarter. Morgan Stanley now owns 8,693,237 shares of the healthcare conglomerate’s stock valued at $3,481,120,000 after acquiring an additional 768,188 shares in the last quarter. 86.20% of the stock is owned by hedge funds and other institutional investors.
About UnitedHealth Group
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.